After falling below Wall Street expectations last quarter, Medifast (NYSE:MED) will report its latest results on Thursday.
Analysts currently expect Medifast to come in with earnings of 37 cents per share on revenues of $90.3 million. Analyst estimates range from earnings per share to earnings per share. Over the past three months, the average estimate has moved down from 41 cents.
In terms of price changes, the stock's best recent streak was when it gained $2.46 per share between June 4, 2012 and June 19, 2012.
Company Fundamental Trends
Analysts think investors should stand pat on Medifast with three of six analysts rating it hold. Analyst sentiment has been improving recently, as the average rating risen slightly over the past three months.
Last Quarter's Results
In the first quarter, profit fell 37.2% to $4 million (29 cents a share) from $6.4 million (44 cents a share) the year earlier, missing analyst expectations. Revenue rose 19.7% to $88.9 million from $74.3 million.
Reporting Period: 2Q
Date of Release: Thursday, July 26, 2012
EPS: 37 cents
Revenue Estimate: $90.3 million
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)